Gene · 4090
Papers3,438
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,438
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Neo-Antigen-Reactive T Cells Immunotherapy for Colorectal Cancer: A More Personalized Cancer Therapy Approach. | Glob Chall | 2023 | 37970536 | PubTator, text mining | PubMed |
| Effects of different signaling pathways on odontogenic differentiation of dental pulp stem cells: a review. | Front Physiol | 2023 | 37929208 | PubTator, text mining | PubMed |
| Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome. | Front Endocrinol (Lausanne) | 2023 | 37929034 | PubTator, text mining | PubMed |
| Multi-organ hereditary hemorrhagic telangiectasia: A case report. | World J Clin Cases | 2023 | 37901025 | PubTator, text mining | PubMed |
| Exploring TCR-like CAR-Engineered Lymphocyte Cytotoxicity against MAGE-A4. | Int J Mol Sci | 2023 | 37894816 | PubTator, text mining | PubMed |
| The Role of the Transforming Growth Factor-β Signaling Pathway in Gastrointestinal Cancers. | Biomolecules | 2023 | 37892233 | PubTator, text mining | PubMed |
| Statistical modeling of extracellular vesicle cargo to predict clinical trial outcomes for hypoplastic left heart syndrome. | iScience | 2023 | 37868626 | PubTator, text mining | PubMed |
| Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker. | Eur J Med Res | 2023 | 37848933 | PubTator, text mining | PubMed |
| uAUG creating variants in the 5'UTR of ENG causing Hereditary Hemorrhagic Telangiectasia. | NPJ Genom Med | 2023 | 37848456 | PubTator, text mining | PubMed |
| Identify the influences of systemic lupus erythematosus on acquired ADAMTS13-deficient thrombotic thrombocytopenic purpura using comprehensive bioinformatics analysis. | Lupus | 2023 | 37846867 | PubTator, text mining | PubMed |
| New insights of miRNA molecular mechanisms in breast cancer brain metastasis and therapeutic targets. | Noncoding RNA Res | 2023 | 37818447 | PubTator, text mining | PubMed |
| The odontoblastic differentiation of dental mesenchymal stem cells: molecular regulation mechanism and related genetic syndromes. | Front Cell Dev Biol | 2023 | 37818127 | PubTator, text mining | PubMed |
| Searching for new genes associated with the familial hypercholesterolemia phenotype using whole-genome sequencing and machine learning. | Vavilovskii Zhurnal Genet Selektsii | 2023 | 37808210 | PubTator, text mining | PubMed |
| Activation of BMP4-pSmad1/5 pathway impairs the function of VSMCs in intracranial aneurysms. | Vascul Pharmacol | 2023 | 37774964 | PubTator, text mining | PubMed |
| Mesenchymal stem cell-derived extracellular vesicles for treatment of bone loss within periodontitis in pre-clinical animal models: a meta-analysis. | BMC Oral Health | 2023 | 37773120 | PubTator, text mining | PubMed |
| GDF15 deficiency hinders human trophoblast invasion to mediate pregnancy loss through downregulating Smad1/5 phosphorylation. | iScience | 2023 | 37766993 | PubTator, text mining | PubMed |
| ADAM11 a novel regulator of Wnt and BMP4 signaling in neural crest and cancer. | Front Cell Dev Biol | 2023 | 37766964 | PubTator, text mining | PubMed |
| The TGF-β/UCHL5/Smad2 Axis Contributes to the Pathogenesis of Placenta Accreta. | Int J Mol Sci | 2023 | 37762005 | PubTator, text mining | PubMed |
| Progress in Regenerative Medicine: Exploring Autologous Platelet Concentrates and Their Clinical Applications. | Genes (Basel) | 2023 | 37761809 | PubTator, text mining | PubMed |
| Cancer Cachexia: Underlying Mechanisms and Potential Therapeutic Interventions. | Metabolites | 2023 | 37755304 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4090/papers?page=7